The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Journal for ImmunoTherapy of Cancer
(Nov 2020)
446 Immunopeptidome changes mediated by a novel ERAP1 inhibitor leads to tumor growth inhibition
Fergus Poynton,
Lesley Young,
Peter Joyce,
Martin Quibell,
Jason Shiers,
Carmen Tong,
Kristopher Clark,
Edd James,
Emma Reeves,
Alihussein Remtulla,
Henry Leonard,
Camila de Almeida,
Elisa Lori,
Nicola Ternette,
Andrew Leishman
Affiliations
Fergus Poynton
6University of Oxford, Oxford, UK
Lesley Young
Aff1 grid.417815.e0000000104335842MedImmune Cambridge UK
Peter Joyce
1Grey Wolf Therapeutics Ltd, Oxford, UK
Martin Quibell
1Grey Wolf Therapeutics Ltd, Oxford, UK
Jason Shiers
2Sygnature Discovery, Nottingham, UK
Carmen Tong
2Sygnature Discovery, Nottingham, UK
Kristopher Clark
2Sygnature Discovery, Nottingham, UK
Edd James
3University of Southampton, Southampton, UK
Emma Reeves
3University of Southampton, Southampton, UK
Alihussein Remtulla
4Charles River Laboratories, Portishead, UK
Henry Leonard
4Charles River Laboratories, Portishead, UK
Camila de Almeida
5Certara, Chester, UK
Elisa Lori
3University of Southampton, Southampton, UK
Nicola Ternette
6University of Oxford, Oxford, UK
Andrew Leishman
1Grey Wolf Therapeutics Ltd, Oxford, UK
DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0446
Journal volume & issue
Vol. 8, no. Suppl 3
Abstract
Read online
No abstracts available.
WeChat QR code
Close